Clinical Trial Detail

NCT ID NCT04337970
Title Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

renal cell carcinoma

Therapies

Axitinib + Talazoparib

Age Groups: senior adult

No variant requirements are available.